Skip to Content
IMPW 2018-Emma WalmsleyIMPW 2018-Emma Walmsley
Courtesy of GlaxoSmithKline
1

Emma Walmsley

  • Title
    CEO
  • Company
    GlaxoSmithKline
  • Country
    U.K.
  • Age
    49

Walmsley has held the top job at GSK, the $38.9 billion British pharma firm, for 17 months, and she has been quick in bringing change to the 300-year old company. In March, she purchased Novartis’s 36% stake in GSK Consumer Health, the joint venture the two firms formed in 2014 and which, as one of the world’s largest OTC businesses, did $9.4 billion in sales last year. In July, she did a $300 million deal with 23andMe, the data-rich direct-to-consumer genetic testing company, to collaborate on drug development. She’s hired a high profile roster of talent from across the industry and beyond—poaching executives from AstraZeneca, Novartis, Pfizer, Walmart and HSBC among others—and putting them to work on her No. 1 agenda item: reinvigorating drug development at the company.

 

Read: CEO Emma Walmsley’s Bold Prescription for Reviving GlaxoSmithKline

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Personal Information

Country
U.K.
Previous Rank
2
Newcomer?-

Company Financials

2017 Profits
1,972.6
2017 Revenues
38,867.8
Market Value as of 08/30/18 ($M)
102,588.5